selected publications
- CEACAM6: A Novel Marker of Chronic Obstructive Pulmonary Disease Susceptibility?. American journal of respiratory and critical care medicine. 2023 Editorial Article GET IT
-
Targeting fibrosis, mechanisms and cilinical trials.
Signal transduction and targeted therapy.
2022
Review
GET IT
Times cited: 195 -
Integrative metabolomic and proteomic signatures define clinical outcomes in severe COVID-19.
iScience.
2022
Academic Article
GET IT
Times cited: 7 -
Angiopoietin 2 Is Associated with Vascular Necroptosis Induction in Coronavirus Disease 2019 Acute Respiratory Distress Syndrome.
The American journal of pathology.
2022
Academic Article
GET IT
Times cited: 18 - Lung lymphatic thrombosis and dysfunction caused by cigarette smoke exposure precedes emphysema in mice. Scientific reports. 2022 Academic Article GET IT
- Evaluation of Albumin Kinetics in Critically Ill Patients With Coronavirus Disease 2019 Compared to Those With Sepsis-Induced Acute Respiratory Distress Syndrome. Critical care explorations. 2021 Academic Article GET IT
-
The Saga of Necroptosis in Chronic Obstructive Pulmonary Disease Continues.
American journal of respiratory and critical care medicine.
2021
Editorial Article
GET IT
Times cited: 4 -
Reversal of emphysema by restoration of pulmonary endothelial cells.
The Journal of experimental medicine.
2021
Academic Article
GET IT
Times cited: 42 -
Anti-complement C5 therapy with eculizumab in three cases of critical COVID-19.
2020
GET IT
Times cited: 75 -
Autophagy in chronic lung disease.
Progress in molecular biology and translational science.
2020
Review
GET IT
Times cited: 20 -
Manmade Macrophage Offers a New Therapy for Pulmonary Alveolar Proteinosis.
American journal of respiratory and critical care medicine.
2018
Editorial Article
GET IT
Times cited: 2 -
Autophagy and inflammation in chronic respiratory disease.
Autophagy.
2018
Information Resource
GET IT
Times cited: 374 -
The emergence of vancomycin-resistant enterococcal bacteremia in hematopoietic stem cell transplant recipients.
Leukemia & lymphoma.
2014
Academic Article
GET IT
Times cited: 31 -
Pemetrexed indirectly activates the metabolic kinase AMPK in human carcinomas.
Cancer research.
2010
Academic Article
GET IT
Times cited: 81 -
Therapeutics by cytotoxic metabolite accumulation: pemetrexed causes ZMP accumulation, AMPK activation, and mammalian target of rapamycin inhibition.
Cancer research.
2009
Academic Article
GET IT
Times cited: 136 -
A mouse gene that coordinates epigenetic controls and transcriptional interference to achieve tissue-specific expression.
Molecular and cellular biology.
2007
Academic Article
GET IT
Times cited: 9